|
Antigen |
Function/Characteristics |
Expression |
Reference |
LSCs |
HSCs |
Cell surface markers |
CD123 |
High affinity IL-3 receptor (IL-3α) |
+ |
- |
Jordan et al. (2000) |
CD47 |
Ligand for SIRPα, inhibits phagocytosis |
+ |
- |
Majeti et al. (2009) |
CD96 |
Activation of Antibody dependent cell-mediated toxicity |
++* |
+ |
Hosen et al. (2007) |
CD32 |
Fc-g receptor 2
(FCGR2) |
+ |
- |
Saito et al. (2010) |
CD25 |
High-affinity IL-2
receptor (IL2Rα) |
+ |
- |
Saito et al. (2010) |
CD44 |
Facilitates adhesive interactions, key regulator of AML-LSCs homing to microenvironmental niches |
++* |
+ |
Jin et al. (2006) |
CXCR4 |
Cell membrane receptor, contributes to SDF-1α/CXCR4 interactions |
++* |
+ |
Spoo et al. (2007) |
|
|
|
|
|
Intracellular markers |
AurA |
Mitotic serine/threonine kinases that play a role in cytokinesis during mitosis and cell division |
++* |
+ |
Ochi et al. (2009) |
Mcl-1 |
Plays a critical role in maintenance and survival of LSCs |
++* |
+ |
Yoshimoto et al. (2009) |
TIM-3 |
Regulator of macrophage activation , role with complement-dependent and antibody dependent cell-mediated cellular cytotoxic activities |
+ |
- |
Kikushige et al. (2010) |
NF-κB |
Transcription factor, responsible for LSC antiapoptotic activity |
+ |
- |
Guzman et al. (2001) |
Abbreviations: IL, interleukin; SIRPα, signal regulatory protein α; SDF, stromal cell-derived factor; LSCs, leukaemic Stem Cells; HSCs, haematopoietic stem cells; CXCR4,
C-X-C chemokine receptor type 4; AurA, Aurora A kinase; Mcl-1, myeloid cell leukaemia-1; TIM-3, T cell immunoglobulin mucin-3; NF-κb, nuclear factor-κB. *Increased
expression |